These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12690954)

  • 1. GPCR drug discovery through the exploitation of allosteric drug binding sites.
    Rees S; Morrow D; Kenakin T
    Recept Channels; 2002; 8(5-6):261-8. PubMed ID: 12690954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor allosterism and complexing.
    Christopoulos A; Kenakin T
    Pharmacol Rev; 2002 Jun; 54(2):323-74. PubMed ID: 12037145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric coupling and biased agonism in G protein-coupled receptors.
    Bock A; Bermudez M
    FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional assay systems for drug discovery at G-protein coupled receptors and ion channels.
    Rees S
    Recept Channels; 2002; 8(5-6):257-9. PubMed ID: 12690953
    [No Abstract]   [Full Text] [Related]  

  • 5. An industrial perspective on utilizing functional ion channel assays for high throughput screening.
    Worley JF; Main MJ
    Recept Channels; 2002; 8(5-6):269-82. PubMed ID: 12690955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.
    Cavasotto CN; Orry AJ; Abagyan RA
    Proteins; 2003 May; 51(3):423-33. PubMed ID: 12696053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of dualsteric GPCR ligands: quests and promise.
    Mohr K; Tränkle C; Kostenis E; Barocelli E; De Amici M; Holzgrabe U
    Br J Pharmacol; 2010 Mar; 159(5):997-1008. PubMed ID: 20136835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutively activated G protein-coupled receptors: a novel approach to CNS drug discovery.
    Menzaghi F; Behan DP; Chalmers DT
    Curr Drug Targets CNS Neurol Disord; 2002 Feb; 1(1):105-21. PubMed ID: 12769637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors.
    Gruber CW; Muttenthaler M; Freissmuth M
    Curr Pharm Des; 2010; 16(28):3071-88. PubMed ID: 20687879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulators of G-protein-coupled receptors.
    May LT; Christopoulos A
    Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.
    Hudson BD; Ulven T; Milligan G
    Curr Top Med Chem; 2013; 13(1):14-25. PubMed ID: 23409763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
    Fronik P; Gaiser BI; Sejer Pedersen D
    J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional assays for identifying ligands at orphan G protein-coupled receptors.
    Szekeres PG
    Recept Channels; 2002; 8(5-6):297-308. PubMed ID: 12690957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of fluorescent peptide G protein-coupled receptor activation biosensors for NanoBRET characterization of intracellular allosteric modulators.
    Farmer JP; Mistry SN; Laughton CA; Holliday ND
    FASEB J; 2022 Nov; 36(11):e22576. PubMed ID: 36183332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast assays for G-protein-coupled receptors.
    Dowell SJ; Brown AJ
    Recept Channels; 2002; 8(5-6):343-52. PubMed ID: 12690961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulation of G protein-coupled receptors.
    May LT; Leach K; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
    Eglen RM; Bosse R; Reisine T
    Assay Drug Dev Technol; 2007 Jun; 5(3):425-51. PubMed ID: 17638542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
    De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
    Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug design strategies for targeting G-protein-coupled receptors.
    Klabunde T; Hessler G
    Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic insights into sodium ion-mediated ligand binding affinity and modulation of 5-HT2B GPCR activity: implications for drug discovery and development.
    Chauhan A; Singh J; Sangwan N; Avti PK
    J Recept Signal Transduct Res; 2024 Feb; 44(1):8-18. PubMed ID: 38529713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.